Celis is leading a revolution in breath test industry to deliver the greatest benefit to patients and healthcare providers globally.
![Pioneering Innovation for better [[healthcare]]](/data/attached/image/20251125/20251125133744_87662.png)
![Pioneering Innovation for better [[future]]](/data/attached/image/20251124/20251124102005_72492.png)
Bridging technology and patient care
Powered by science and technology, we design personalized solutions that elevate clinical practice and improve patient care. This commitment guides every innovation we create for healthcare professionals and their patients.
![[[Bridging]] technology and patient care](/data/attached/image/20251124/20251124112900_75523.png)
![[[Barriers to]] care have grown significantly over the past five years 2.](/data/attached/image/20251124/20251124113332_18856.png)
![[[Barriers to]] care have grown significantly over the past five years 3.](/data/attached/image/20251124/20251124114057_71569.png)
![Reliable partner in [[Gastroenterology]]](/data/attached/image/20251210/20251210090613_22086.jpg)
Reliable partner in Gastroenterology
Our goal is to stand alone as the premier supplier—a partner—in the advancement of Gastroenterological care. Through an open-minded approach to innovation, and high-impact connections to world-renowned opinion leaders, we drive science in the GI space. Celis Biotech delivers, and continuously improves, a comprehensive range of diagnostic GI applications through organic product development and strategic acquisitions.
In 1994, H. pylori was categorized as a class I (definite) carcinogen by WHO
Helicobacter pylori is a bacterium which infects the lining of the stomach and is responsible for a high percentage of stomach and duodenal ulcers and is associated with stomach cancer and MALT lymphoma. According to World Gastroenterology Organization guideline, about 50% of the world population are infected. It is thought that the bacterium is spread via person-to-person contact. It is common for H. pylori to be spread between family members. When a diagnosis of H. pylori infection is made, it is now advisable for immediate family members to be also breath tested and treated.
![In 1994, [[H. pylori was categorized as a class I (definite) carcinogen]] by WHO](/data/attached/image/20251124/20251124140926_27016.png)
Celis H pylori Urea breath test system.
Sensitivity: 95%+; Specificity: 95%+; Plug-and-play for immediate use; Simple installation and low maintenance; Portable design with user-friendly software; A Next-Generation smart diagnostic platform designed for accuracy, convenience, and modern clinical workflows.
![Celis [[H pylori]] Urea breath test system.](/data/attached/image/20251124/20251124180635_76760.png)
A simple breath, H pylori diagnosed!
Urea breath test (UBT) is regarded as a gold standard non-invasive method for H. pylori diagnosis. It uses a sample of exhaled breath to determine ongoing active H. pylori infection. It provides a rapid, reliable, and non-invasive way of both initial diagnosis and following treatment.